Protopapas Anna is a director of Mersana Therapeutics Inc.
Person profile
Roles
Mersana Therapeutics
Director
Nuvalent Inc - Ordinary Shares
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Mersana Therapeutics, Inc.
17 Jan 24
144
Mersana Therapeutics, Inc.
16 Jan 24
4
Nuvalent, Inc.
20 Dec 23
144
Nuvalent, Inc.
18 Dec 23
4
Mersana Therapeutics, Inc.
13 Sep 23
4
Nuvalent, Inc.
16 Jun 23
4
Mersana Therapeutics, Inc.
18 Jan 23
4
Nuvalent, Inc.
17 Jun 22
4
Nuvalent, Inc.
31 Mar 22
3
Nuvalent, Inc.
31 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | MRSN Mersana Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 2.71 | 29,399 | 79.67 k | 125,153 |
15 Jan 24 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 17,708 | 0.00 | 154,552 |
15 Jan 24 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 21,250 | 0.00 | 136,844 |
15 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 17,708 | 0.00 | 0 |
15 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 21,250 | 0.00 | 21,250 |
14 Jan 24 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 16,750 | 0.00 | 115,594 |
14 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 16,750 | 0.00 | 33,500 |
13 Jan 24 | MRSN Mersana Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 31,250 | 0.00 | 98,844 |
13 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 31,250 | 0.00 | 93,750 |
18 Dec 23 | NUVL Nuvalent Inc - Ordinary Shares | Class A Common Stock | Sell | Dispose S | No | No | 75.67 | 5,000 | 378.35 k | 0 |